BindingDB logo
myBDB logout

null

SMILES: CC(C)O[C@H]1CC[C@@H](OC1)C(=O)N1Cc2cccnc2Nc2ccc(cc12)C1COCCO1

InChI Key: InChIKey=TUICWOOCJAYCCE-BEUBQONESA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 415726   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H]


(Homo sapiens (Human))
BDBM415726
PNG
((8-(1,4-dioxan-2-yl)-5,11- dihydro-6H-benzo[b]pyri...)
Show SMILES CC(C)O[C@H]1CC[C@@H](OC1)C(=O)N1Cc2cccnc2Nc2ccc(cc12)C1COCCO1 |r|
Show InChI InChI=1S/C25H31N3O5/c1-16(2)33-19-6-8-22(32-14-19)25(29)28-13-18-4-3-9-26-24(18)27-20-7-5-17(12-21(20)28)23-15-30-10-11-31-23/h3-5,7,9,12,16,19,22-23H,6,8,10-11,13-15H2,1-2H3,(H,26,27)/t19-,22+,23?/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 42n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp...


US Patent US10442819 (2019)


BindingDB Entry DOI: 10.7270/Q2HQ428F
More data for this
Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic


(Homo sapiens (Human))
BDBM415726
PNG
((8-(1,4-dioxan-2-yl)-5,11- dihydro-6H-benzo[b]pyri...)
Show SMILES CC(C)O[C@H]1CC[C@@H](OC1)C(=O)N1Cc2cccnc2Nc2ccc(cc12)C1COCCO1 |r|
Show InChI InChI=1S/C25H31N3O5/c1-16(2)33-19-6-8-22(32-14-19)25(29)28-13-18-4-3-9-26-24(18)27-20-7-5-17(12-21(20)28)23-15-30-10-11-31-23/h3-5,7,9,12,16,19,22-23H,6,8,10-11,13-15H2,1-2H3,(H,26,27)/t19-,22+,23?/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 42n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of IDH1 R132H mutant (unknown origin) assessed as reduction in NADPH consumption using alpha-KG as substrate incubated for 60 mins by Kina...


Citation and Details

Article DOI: 10.1021/acsmedchemlett.2c00089
BindingDB Entry DOI: 10.7270/Q2RJ4PCP
More data for this
Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H]


(Homo sapiens (Human))
BDBM415726
PNG
((8-(1,4-dioxan-2-yl)-5,11- dihydro-6H-benzo[b]pyri...)
Show SMILES CC(C)O[C@H]1CC[C@@H](OC1)C(=O)N1Cc2cccnc2Nc2ccc(cc12)C1COCCO1 |r|
Show InChI InChI=1S/C25H31N3O5/c1-16(2)33-19-6-8-22(32-14-19)25(29)28-13-18-4-3-9-26-24(18)27-20-7-5-17(12-21(20)28)23-15-30-10-11-31-23/h3-5,7,9,12,16,19,22-23H,6,8,10-11,13-15H2,1-2H3,(H,26,27)/t19-,22+,23?/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 58n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp...


US Patent US10442819 (2019)


BindingDB Entry DOI: 10.7270/Q2HQ428F
More data for this
Ligand-Target Pair